Programmed cell death 1 (PD-1) receptor is expressed on different immune cells, including tumor-infiltrating lymphocytes (TILs), and binds to PD-L1, which is expressed on myeloid regulatory cells and nonimmune cells such as malignant cells (Figure 1). Here, CD274 is linked to neoplasm.